Essential Pharma valuation, funding and investors
Essential Pharma works in specialty pharmaceutical development, based in Egham, United Kingdom. Founded in 2000, it has about 122 employees.
VALUATION · TODAY
$11.67B +0% after Growth
Range $5.25B – $17.77B · Grade CTODAY
+12 MO
$5.00B
$10.00B
$15.00B
$20.00B
2001
2003
2005
2007
2009
2011
2013
2015
2017
2019
2021
2023
2025
2027
Growth $946M
ValuationBefore first round12-month outlook: where it points, how wide it fansHover the past: the outlook shows what was predicted then
HEADCOUNT · TODAY122 employees
+10%6m growth
+17%1y growth
+61%2y growth
50
100
150
Data from Jan 2021
Predicted in 1 yr $11.67B +0% vs today
Predicted next raise $1.15B if a round comes
Winding-down probability 0%
- Last round
- Growth · $946M · Dec 2024
- Valuation at last round
- $9.64B · implied
- Headcount
- 122 · up
- Grade
- C
- Founded
- 2000
Essential Pharma valuation today
VCMC values Essential Pharma at $11.7B today, with a range of $5.3B to $17.8B and a grade of C. The valuation starts from its last funding round, a growth round in Dec 2024.
Valuation by date (324 rows)
Each point is what the model would have shown on that date, using only what was known then; before its first round, a company is valued as a startup because it later raised.
| Date | Valuation | Range | Predicted in 1 yr | Phase | Headcount | Trend | Grade | Winding-down probability |
|---|---|---|---|---|---|---|---|---|
| 1 Jan 2000 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Feb 2000 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Mar 2000 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Apr 2000 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 May 2000 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jun 2000 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jul 2000 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Aug 2000 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Sep 2000 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Oct 2000 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Nov 2000 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Dec 2000 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jan 2001 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Feb 2001 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Mar 2001 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Apr 2001 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 May 2001 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jun 2001 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jul 2001 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Aug 2001 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Sep 2001 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Oct 2001 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Nov 2001 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Dec 2001 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jan 2002 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Feb 2002 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Mar 2002 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Apr 2002 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 May 2002 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jun 2002 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jul 2002 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Aug 2002 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Sep 2002 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Oct 2002 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Nov 2002 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Dec 2002 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jan 2003 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Feb 2003 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Mar 2003 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Apr 2003 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 May 2003 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jun 2003 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jul 2003 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Aug 2003 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Sep 2003 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Oct 2003 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Nov 2003 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Dec 2003 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jan 2004 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Feb 2004 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Mar 2004 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Apr 2004 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 May 2004 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jun 2004 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jul 2004 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Aug 2004 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Sep 2004 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Oct 2004 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Nov 2004 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Dec 2004 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jan 2005 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Feb 2005 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Mar 2005 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Apr 2005 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 May 2005 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jun 2005 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jul 2005 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Aug 2005 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Sep 2005 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Oct 2005 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Nov 2005 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Dec 2005 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jan 2006 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Feb 2006 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Mar 2006 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Apr 2006 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 May 2006 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jun 2006 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jul 2006 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Aug 2006 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Sep 2006 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Oct 2006 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Nov 2006 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Dec 2006 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jan 2007 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Feb 2007 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Mar 2007 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Apr 2007 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 May 2007 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jun 2007 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jul 2007 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Aug 2007 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Sep 2007 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Oct 2007 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Nov 2007 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Dec 2007 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jan 2008 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Feb 2008 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Mar 2008 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Apr 2008 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 May 2008 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jun 2008 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jul 2008 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Aug 2008 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Sep 2008 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Oct 2008 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Nov 2008 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Dec 2008 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jan 2009 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Feb 2009 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Mar 2009 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Apr 2009 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 May 2009 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jun 2009 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jul 2009 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Aug 2009 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Sep 2009 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Oct 2009 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Nov 2009 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Dec 2009 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jan 2010 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Feb 2010 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Mar 2010 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Apr 2010 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 May 2010 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jun 2010 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jul 2010 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Aug 2010 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Sep 2010 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Oct 2010 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Nov 2010 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Dec 2010 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jan 2011 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Feb 2011 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Mar 2011 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Apr 2011 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 May 2011 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jun 2011 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Jul 2011 | $2.92M | $1.06M – $8.03M | $2.92M (0%) | before first round | – | unknown | D | 0% |
| 1 Aug 2011 | $2.92M | $1.06M – $8.03M | $2.94M (0%) | before first round | – | unknown | D | 0% |
| 1 Sep 2011 | $2.92M | $1.06M – $8.03M | $2.95M (+1%) | before first round | – | unknown | D | 0% |
| 1 Oct 2011 | $2.92M | $1.06M – $8.03M | $2.96M (+1%) | before first round | – | unknown | D | 0% |
| 1 Nov 2011 | $2.92M | $1.06M – $8.03M | $2.97M (+2%) | before first round | – | unknown | D | 0% |
| 1 Dec 2011 | $2.92M | $1.06M – $8.03M | $2.98M (+2%) | before first round | – | unknown | D | 0% |
| 1 Jan 2012 | $2.92M | $1.06M – $8.03M | $2.99M (+2%) | before first round | – | unknown | D | 0% |
| 1 Feb 2012 | $2.92M | $1.06M – $8.03M | $3.01M (+3%) | before first round | – | unknown | D | 0% |
| 1 Mar 2012 | $2.92M | $1.06M – $8.03M | $3.02M (+3%) | before first round | – | unknown | D | 0% |
| 1 Apr 2012 | $2.92M | $1.06M – $8.03M | $3.03M (+4%) | before first round | – | unknown | D | 0% |
| 1 May 2012 | $2.92M | $1.06M – $8.03M | $3.04M (+4%) | before first round | – | unknown | D | 0% |
| 1 Jun 2012 | $2.92M | $1.06M – $8.03M | $3.05M (+4%) | before first round | – | unknown | D | 0% |
| 1 Jul 2012 | $2.92M | $1.06M – $8.03M | $3.06M (+5%) | before first round | – | unknown | D | 0% |
| 1 Aug 2012 | $2.94M | $1.07M – $8.07M | $3.08M (+5%) | before first round | – | unknown | D | 0% |
| 1 Sep 2012 | $2.95M | $1.07M – $8.10M | $3.09M (+5%) | before first round | – | unknown | D | 0% |
| 1 Oct 2012 | $2.96M | $1.08M – $8.13M | $3.10M (+5%) | before first round | – | unknown | D | 0% |
| 1 Nov 2012 | $2.97M | $1.08M – $8.16M | $3.11M (+5%) | before first round | – | unknown | D | 0% |
| 1 Dec 2012 | $2.98M | $1.09M – $8.19M | $3.13M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jan 2013 | $2.99M | $1.09M – $8.22M | $3.14M (+5%) | before first round | – | unknown | D | 0% |
| 1 Feb 2013 | $3.01M | $1.09M – $8.26M | $3.15M (+5%) | before first round | – | unknown | D | 0% |
| 1 Mar 2013 | $3.02M | $1.10M – $8.29M | $3.16M (+5%) | before first round | – | unknown | D | 0% |
| 1 Apr 2013 | $3.03M | $1.10M – $8.32M | $3.17M (+5%) | before first round | – | unknown | D | 0% |
| 1 May 2013 | $3.04M | $1.11M – $8.35M | $3.19M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jun 2013 | $3.05M | $1.11M – $8.39M | $3.20M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jul 2013 | $3.06M | $1.12M – $8.42M | $3.21M (+5%) | before first round | – | unknown | D | 0% |
| 1 Aug 2013 | $3.08M | $1.12M – $8.45M | $3.22M (+5%) | before first round | – | unknown | D | 0% |
| 1 Sep 2013 | $3.09M | $1.12M – $8.49M | $3.24M (+5%) | before first round | – | unknown | D | 0% |
| 1 Oct 2013 | $3.10M | $1.13M – $8.52M | $3.25M (+5%) | before first round | – | unknown | D | 0% |
| 1 Nov 2013 | $3.11M | $1.13M – $8.55M | $3.26M (+5%) | before first round | – | unknown | D | 0% |
| 1 Dec 2013 | $3.13M | $1.14M – $8.58M | $3.28M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jan 2014 | $3.14M | $1.14M – $8.62M | $3.29M (+5%) | before first round | – | unknown | D | 0% |
| 1 Feb 2014 | $3.15M | $1.15M – $8.65M | $3.30M (+5%) | before first round | – | unknown | D | 0% |
| 1 Mar 2014 | $3.16M | $1.15M – $8.68M | $3.31M (+5%) | before first round | – | unknown | D | 0% |
| 1 Apr 2014 | $3.17M | $1.16M – $8.72M | $3.33M (+5%) | before first round | – | unknown | D | 0% |
| 1 May 2014 | $3.19M | $1.16M – $8.75M | $3.34M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jun 2014 | $3.20M | $1.16M – $8.79M | $3.35M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jul 2014 | $3.21M | $1.17M – $8.82M | $3.37M (+5%) | before first round | – | unknown | D | 0% |
| 1 Aug 2014 | $3.22M | $1.17M – $8.86M | $3.38M (+5%) | before first round | – | unknown | D | 0% |
| 1 Sep 2014 | $3.24M | $1.18M – $8.89M | $3.39M (+5%) | before first round | – | unknown | D | 0% |
| 1 Oct 2014 | $3.25M | $1.18M – $8.93M | $3.41M (+5%) | before first round | – | unknown | D | 0% |
| 1 Nov 2014 | $3.26M | $1.19M – $8.96M | $3.42M (+5%) | before first round | – | unknown | D | 0% |
| 1 Dec 2014 | $3.28M | $1.19M – $9.00M | $3.43M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jan 2015 | $3.29M | $1.20M – $9.03M | $3.45M (+5%) | before first round | – | unknown | D | 0% |
| 1 Feb 2015 | $3.30M | $1.20M – $9.07M | $3.46M (+5%) | before first round | – | unknown | D | 0% |
| 1 Mar 2015 | $3.31M | $1.21M – $9.10M | $3.47M (+5%) | before first round | – | unknown | D | 0% |
| 1 Apr 2015 | $3.33M | $1.21M – $9.14M | $3.49M (+5%) | before first round | – | unknown | D | 0% |
| 1 May 2015 | $3.34M | $1.22M – $9.17M | $3.50M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jun 2015 | $3.35M | $1.22M – $9.21M | $3.51M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jul 2015 | $3.37M | $1.23M – $9.24M | $3.53M (+5%) | before first round | – | unknown | D | 0% |
| 1 Aug 2015 | $3.38M | $1.23M – $9.28M | $3.62M (+7%) | before first round | – | unknown | D | 0% |
| 1 Sep 2015 | $3.39M | $1.23M – $9.32M | $3.72M (+10%) | before first round | – | unknown | D | 0% |
| 1 Oct 2015 | $3.41M | $1.24M – $9.35M | $3.81M (+12%) | before first round | – | unknown | D | 0% |
| 1 Nov 2015 | $3.42M | $1.24M – $9.39M | $3.92M (+15%) | before first round | – | unknown | D | 0% |
| 1 Dec 2015 | $3.43M | $1.25M – $9.43M | $4.02M (+17%) | before first round | – | unknown | D | 0% |
| 1 Jan 2016 | $3.45M | $1.25M – $9.47M | $4.13M (+20%) | before first round | – | unknown | D | 0% |
| 1 Feb 2016 | $3.46M | $1.26M – $9.50M | $4.24M (+23%) | before first round | – | unknown | D | 0% |
| 1 Mar 2016 | $3.47M | $1.26M – $9.54M | $4.35M (+25%) | before first round | – | unknown | D | 0% |
| 1 Apr 2016 | $3.49M | $1.27M – $9.58M | $4.47M (+28%) | before first round | – | unknown | D | 0% |
| 1 May 2016 | $3.50M | $1.27M – $9.61M | $4.59M (+31%) | before first round | – | unknown | D | 0% |
| 1 Jun 2016 | $3.51M | $1.28M – $9.65M | $4.71M (+34%) | before first round | – | unknown | D | 0% |
| 1 Jul 2016 | $3.53M | $1.28M – $9.69M | $4.83M (+37%) | before first round | – | unknown | D | 0% |
| 1 Aug 2016 | $3.62M | $1.32M – $9.95M | $4.96M (+37%) | before first round | – | unknown | D | 0% |
| 1 Sep 2016 | $3.72M | $1.35M – $10.2M | $5.10M (+37%) | before first round | – | unknown | D | 0% |
| 1 Oct 2016 | $3.82M | $1.39M – $10.5M | $5.23M (+37%) | before first round | – | unknown | D | 0% |
| 1 Nov 2016 | $3.92M | $1.43M – $10.8M | $5.38M (+37%) | before first round | – | unknown | D | 0% |
| 1 Dec 2016 | $4.02M | $1.46M – $11.1M | $5.52M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jan 2017 | $4.13M | $1.50M – $11.3M | $5.66M (+37%) | before first round | – | unknown | D | 0% |
| 1 Feb 2017 | $4.24M | $1.54M – $11.7M | $5.82M (+37%) | before first round | – | unknown | D | 0% |
| 1 Mar 2017 | $4.35M | $1.58M – $11.9M | $5.96M (+37%) | before first round | – | unknown | D | 0% |
| 1 Apr 2017 | $4.46M | $1.63M – $12.3M | $6.12M (+37%) | before first round | – | unknown | D | 0% |
| 1 May 2017 | $4.58M | $1.67M – $12.6M | $6.28M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jun 2017 | $4.71M | $1.71M – $12.9M | $6.45M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jul 2017 | $4.83M | $1.76M – $13.3M | $6.62M (+37%) | before first round | – | unknown | D | 0% |
| 1 Aug 2017 | $4.96M | $1.81M – $13.6M | $6.80M (+37%) | before first round | – | unknown | D | 0% |
| 1 Sep 2017 | $5.10M | $1.85M – $14.0M | $6.99M (+37%) | before first round | – | unknown | D | 0% |
| 1 Oct 2017 | $5.23M | $1.90M – $14.4M | $7.17M (+37%) | before first round | – | unknown | D | 0% |
| 1 Nov 2017 | $5.37M | $1.96M – $14.8M | $7.36M (+37%) | before first round | – | unknown | D | 0% |
| 1 Dec 2017 | $5.51M | $2.01M – $15.1M | $7.56M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jan 2018 | $5.66M | $2.06M – $15.6M | $7.76M (+37%) | before first round | – | unknown | D | 0% |
| 1 Feb 2018 | $5.82M | $2.12M – $16.0M | $7.97M (+37%) | before first round | – | unknown | D | 0% |
| 1 Mar 2018 | $5.96M | $2.17M – $16.4M | $8.17M (+37%) | before first round | – | unknown | D | 0% |
| 1 Apr 2018 | $6.12M | $2.23M – $16.8M | $8.39M (+37%) | before first round | – | unknown | D | 0% |
| 1 May 2018 | $6.28M | $2.29M – $17.3M | $8.61M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jun 2018 | $6.45M | $2.35M – $17.7M | $8.85M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jul 2018 | $6.62M | $2.41M – $18.2M | $9.08M (+37%) | before first round | – | unknown | D | 0% |
| 1 Aug 2018 | $6.80M | $2.48M – $18.7M | $9.17M (+35%) | before first round | – | unknown | D | 0% |
| 1 Sep 2018 | $6.99M | $2.54M – $19.2M | $9.25M (+32%) | before first round | – | unknown | D | 0% |
| 1 Oct 2018 | $7.17M | $2.61M – $19.7M | $9.34M (+30%) | before first round | – | unknown | D | 0% |
| 1 Nov 2018 | $7.36M | $2.68M – $20.2M | $9.42M (+28%) | before first round | – | unknown | D | 0% |
| 1 Dec 2018 | $7.56M | $2.75M – $20.8M | $9.51M (+26%) | before first round | – | unknown | D | 0% |
| 1 Jan 2019 | $7.76M | $2.83M – $21.3M | $9.59M (+24%) | before first round | – | unknown | D | 0% |
| 1 Feb 2019 | $7.97M | $2.90M – $21.9M | $9.68M (+21%) | before first round | – | unknown | D | 0% |
| 1 Mar 2019 | $8.17M | $2.97M – $22.4M | $9.76M (+19%) | before first round | – | unknown | D | 0% |
| 1 Apr 2019 | $8.39M | $3.05M – $23.1M | $9.85M (+17%) | before first round | – | unknown | D | 0% |
| 1 May 2019 | $8.61M | $3.14M – $23.7M | $9.94M (+15%) | before first round | – | unknown | D | 0% |
| 1 Jun 2019 | $8.85M | $3.22M – $24.3M | $10.0M (+13%) | before first round | – | unknown | D | 0% |
| 1 Jul 2019 | $9.08M | $3.30M – $24.9M | $10.1M (+11%) | before first round | – | unknown | D | 0% |
| 1 Aug 2019 | $9.17M | $3.34M – $25.2M | $10.2M (+11%) | before first round | – | unknown | D | 0% |
| 1 Sep 2019 | $9.25M | $3.37M – $25.4M | $10.3M (+11%) | before first round | – | unknown | D | 0% |
| 1 Oct 2019 | $9.34M | $3.40M – $25.6M | $10.4M (+11%) | before first round | – | unknown | D | 0% |
| 1 Nov 2019 | $9.42M | $3.43M – $25.9M | $10.5M (+11%) | before first round | – | unknown | D | 0% |
| 1 Dec 2019 | $9.51M | $3.46M – $26.1M | $10.6M (+11%) | before first round | – | unknown | D | 0% |
| 1 Jan 2020 | $9.59M | $3.49M – $26.4M | $10.7M (+11%) | before first round | – | unknown | D | 0% |
| 1 Feb 2020 | $9.68M | $3.52M – $26.6M | $10.8M (+11%) | before first round | – | unknown | D | 0% |
| 1 Mar 2020 | $9.76M | $3.55M – $26.8M | $10.9M (+11%) | before first round | – | unknown | D | 0% |
| 1 Apr 2020 | $9.85M | $3.59M – $27.1M | $11.0M (+11%) | before first round | – | unknown | D | 0% |
| 1 May 2020 | $9.94M | $3.62M – $27.3M | $11.1M (+11%) | before first round | – | unknown | D | 0% |
| 1 Jun 2020 | $10.0M | $3.65M – $27.6M | $11.2M (+11%) | before first round | – | unknown | D | 0% |
| 1 Jul 2020 | $10.1M | $3.69M – $27.8M | $11.3M (+11%) | before first round | – | unknown | D | 0% |
| 1 Aug 2020 | $10.2M | $3.72M – $28.1M | $11.4M (+11%) | before first round | – | unknown | D | 0% |
| 1 Sep 2020 | $10.3M | $3.75M – $28.3M | $11.5M (+11%) | before first round | – | unknown | D | 0% |
| 1 Oct 2020 | $10.4M | $3.79M – $28.6M | $11.6M (+11%) | before first round | – | unknown | D | 0% |
| 1 Nov 2020 | $10.5M | $3.82M – $28.8M | $11.7M (+11%) | before first round | – | unknown | D | 0% |
| 1 Dec 2020 | $10.6M | $3.86M – $29.1M | $11.8M (+11%) | before first round | – | unknown | D | 0% |
| 1 Jan 2021 | $2.37M | $0.50M – $11.4M | $2.45M (+3%) | before first round | 9 | unknown | D | 0% |
| 1 Feb 2021 | $2.38M | $0.50M – $11.4M | $2.45M (+3%) | before first round | 9 | unknown | D | 0% |
| 1 Mar 2021 | $2.39M | $0.50M – $11.4M | $2.46M (+3%) | before first round | 9 | unknown | D | 0% |
| 1 Apr 2021 | $2.39M | $0.50M – $11.4M | $2.46M (+3%) | before first round | 9 | unknown | D | 0% |
| 1 May 2021 | $2.40M | $0.50M – $11.5M | $2.47M (+3%) | before first round | 9 | unknown | D | 0% |
| 1 Jun 2021 | $2.40M | $0.50M – $11.5M | $2.48M (+3%) | before first round | 9 | unknown | D | 0% |
| 1 Jul 2021 | $2.41M | $0.50M – $11.5M | $2.48M (+3%) | before first round | 9 | unknown | D | 0% |
| 1 Aug 2021 | $2.42M | $0.50M – $11.6M | $2.49M (+3%) | before first round | 9 | unknown | D | 0% |
| 1 Sep 2021 | $2.42M | $0.51M – $11.6M | $2.49M (+3%) | before first round | 9 | unknown | D | 0% |
| 1 Oct 2021 | $2.43M | $0.51M – $11.6M | $2.50M (+3%) | before first round | 9 | unknown | D | 0% |
| 1 Nov 2021 | $2.44M | $0.51M – $11.7M | $2.50M (+3%) | before first round | 9 | unknown | D | 0% |
| 1 Dec 2021 | $2.44M | $0.51M – $11.7M | $2.51M (+3%) | before first round | 9 | unknown | D | 0% |
| 1 Jan 2022 | $2.45M | $0.51M – $11.7M | $2.51M (+3%) | before first round | 9 | unknown | D | 0% |
| 1 Feb 2022 | $10.1M | $2.47M – $34.8M | $10.3M (+3%) | before first round | 38 | growing | D | 0% |
| 1 Mar 2022 | $10.1M | $2.48M – $34.9M | $10.3M (+3%) | before first round | 38 | growing | D | 0% |
| 1 Apr 2022 | $10.1M | $2.48M – $35.0M | $10.4M (+3%) | before first round | 38 | growing | D | 0% |
| 1 May 2022 | $10.1M | $2.49M – $35.0M | $10.4M (+3%) | before first round | 38 | growing | D | 0% |
| 1 Jun 2022 | $10.1M | $2.49M – $35.1M | $10.4M (+3%) | before first round | 38 | growing | D | 0% |
| 1 Jul 2022 | $10.2M | $2.50M – $35.2M | $10.4M (+3%) | before first round | 38 | growing | D | 0% |
| 1 Aug 2022 | $10.2M | $2.50M – $35.3M | $10.5M (+3%) | before first round | 38 | growing | D | 0% |
| 1 Sep 2022 | $10.2M | $2.51M – $35.3M | $10.5M (+3%) | before first round | 38 | growing | D | 0% |
| 1 Oct 2022 | $10.2M | $2.52M – $35.4M | $10.5M (+3%) | before first round | 38 | growing | D | 0% |
| 1 Nov 2022 | $7.42M | $1.55M – $35.5M | $7.61M (+3%) | before first round | 38 | unknown | D | 0% |
| 1 Dec 2022 | $7.43M | $1.55M – $35.6M | $7.63M (+3%) | before first round | 38 | unknown | D | 0% |
| 1 Jan 2023 | $14.9M | $3.66M – $51.6M | $15.3M (+3%) | before first round | 62 | growing | D | 0% |
| 1 Feb 2023 | $14.9M | $3.67M – $51.7M | $15.3M (+3%) | before first round | 62 | growing | D | 0% |
| 1 Mar 2023 | $15.0M | $3.68M – $51.8M | $15.4M (+3%) | before first round | 62 | growing | D | 0% |
| 1 Apr 2023 | $15.0M | $3.69M – $51.9M | $15.4M (+3%) | before first round | 62 | growing | D | 0% |
| 1 May 2023 | $15.0M | $3.69M – $52.0M | $15.4M (+3%) | before first round | 62 | growing | D | 0% |
| 1 Jun 2023 | $15.1M | $3.70M – $52.1M | $15.5M (+3%) | before first round | 62 | growing | D | 0% |
| 1 Jul 2023 | $15.1M | $3.71M – $52.2M | $15.5M (+3%) | before first round | 62 | growing | D | 0% |
| 1 Aug 2023 | $15.1M | $3.72M – $52.4M | $15.5M (+2%) | before first round | 62 | growing | D | 0% |
| 1 Sep 2023 | $11.0M | $2.29M – $52.5M | $11.2M (+2%) | before first round | 62 | unknown | D | 0% |
| 1 Oct 2023 | $10.9M | $2.27M – $51.9M | $11.1M (+2%) | before first round | 61 | flat | D | 8% |
| 1 Nov 2023 | $10.9M | $2.27M – $52.1M | $11.1M (+2%) | before first round | 61 | flat | D | 8% |
| 1 Dec 2023 | $10.9M | $2.28M – $52.2M | $11.1M (+2%) | before first round | 61 | flat | D | 8% |
| 1 Jan 2024 | $10.9M | $2.28M – $52.3M | $11.1M (+1%) | before first round | 61 | flat | D | 8% |
| 1 Feb 2024 | $11.6M | $2.43M – $55.6M | $11.7M (+1%) | before first round | 66 | flat | D | 0% |
| 1 Mar 2024 | $11.9M | $2.49M – $57.0M | $12.0M (+1%) | before first round | 68 | flat | D | 0% |
| 1 Apr 2024 | $11.9M | $2.49M – $57.1M | $12.0M (+1%) | before first round | 68 | flat | D | 0% |
| 1 May 2024 | $12.0M | $2.50M – $57.2M | $12.0M (0%) | before first round | 68 | flat | D | 0% |
| 1 Jun 2024 | $12.0M | $2.50M – $57.4M | $12.0M (0%) | before first round | 68 | flat | D | 0% |
| 1 Jul 2024 | $16.0M | $3.02M – $62.5M | $16.0M (0%) | before first round | 76 | up | D | 0% |
| 1 Aug 2024 | $16.0M | $3.02M – $62.5M | $16.0M (0%) | before first round | 76 | up | D | 0% |
| 1 Sep 2024 | $16.0M | $3.02M – $62.5M | $16.0M (0%) | before first round | 76 | up | D | 0% |
| 1 Oct 2024 | $16.0M | $3.02M – $62.5M | $16.0M (0%) | before first round | 76 | up | D | 0% |
| 1 Nov 2024 | $16.5M | $3.11M – $64.4M | $16.5M (0%) | before first round | 79 | up | D | 0% |
| 1 Dec 2024 | $16.5M | $3.11M – $64.4M | $16.5M (0%) | before first round | 79 | up | D | 0% |
| 13 Dec 2024 | $9.6B | $6.3B – $16.1B | $10.6B (+10%) | after a round | 79 | up | B | 0% |
| 1 Jan 2025 | $9.7B | $6.3B – $16.1B | $10.6B (+9%) | after a round | 79 | up | B | 0% |
| 1 Feb 2025 | $9.8B | $6.3B – $16.1B | $10.6B (+9%) | after a round | 79 | up | B | 0% |
| 1 Mar 2025 | $9.8B | $6.3B – $16.1B | $10.6B (+8%) | after a round | 79 | up | B | 0% |
| 1 Apr 2025 | $9.9B | $6.3B – $16.1B | $10.6B (+7%) | after a round | 79 | up | B | 0% |
| 1 May 2025 | $10.0B | $6.3B – $16.1B | $10.6B (+6%) | after a round | 79 | up | B | 0% |
| 1 Jun 2025 | $10.1B | $6.3B – $16.1B | $10.6B (+5%) | after a round | 79 | up | B | 0% |
| 1 Jul 2025 | $10.2B | $6.3B – $16.1B | $10.6B (+4%) | after a round | 79 | up | B | 0% |
| 1 Aug 2025 | $10.6B | $6.7B – $17.1B | $11.2B (+6%) | after a round | 103 | growing | B | 0% |
| 1 Sep 2025 | $10.8B | $6.7B – $17.1B | $11.2B (+4%) | after a round | 103 | growing | B | 0% |
| 1 Oct 2025 | $10.9B | $6.7B – $17.2B | $11.3B (+3%) | after a round | 104 | growing | B | 0% |
| 1 Nov 2025 | $11.1B | $6.8B – $17.3B | $11.3B (+2%) | after a round | 107 | growing | B | 0% |
| 1 Dec 2025 | $11.3B | $6.8B – $17.3B | $11.3B (+1%) | after a round | 107 | growing | B | 0% |
| 1 Jan 2026 | $11.4B | $6.8B – $17.3B | $11.4B (0%) | after a round | 108 | growing | B | 0% |
| 1 Feb 2026 | $11.4B | $6.7B – $17.3B | $11.4B (0%) | after a round | 108 | growing | B | 0% |
| 1 Mar 2026 | $11.4B | $6.7B – $17.4B | $11.4B (0%) | after a round | 111 | growing | B | 0% |
| 1 Apr 2026 | $11.4B | $6.6B – $17.4B | $11.4B (0%) | after a round | 111 | growing | B | 0% |
| 1 May 2026 | $11.5B | $6.6B – $17.5B | $11.5B (0%) | after a round | 113 | growing | B | 0% |
| 1 Jun 2026 | $11.5B | $5.2B – $17.5B | $11.5B (0%) | after a round | 113 | flat | C | 0% |
| 1 Jul 2026 | $11.5B | $4.9B – $17.5B | $11.5B (0%) | after a round | 113 | flat | C | 0% |
| 1 Aug 2026 | $11.6B | $5.6B – $17.7B | $11.6B (0%) | after a round | 119 | up | B | 0% |
| 1 Sep 2026 | $11.7B | $5.5B – $17.8B | $11.7B (0%) | after a round | 122 | up | B | 0% |
| 1 Oct 2026 | $11.7B | $5.4B – $17.8B | $11.7B (0%) | after a round | 122 | up | B | 0% |
| 24 Oct 2026 | $11.7B | $5.3B – $17.8B | $11.7B (0%) | after a round | 122 | up | C | 0% |
Key facts about Essential Pharma
- Founded
- 2000
- Headquarters
- Egham, United Kingdom
- Employees
- about 122 +17% in a year
- Total raised
- $946M
- Funding rounds
- 1
- Last round
- Growth Equity Dec 2024
Essential Pharma funding history
Essential Pharma has 1 funding round on record, from Dec 2024 to Dec 2024, $946M in total. None disclosed a valuation.
Growth Equity 12 Dec 2024
Led by AlpInvest; with Gyrus Capital, Sixth Street.
Sources: globenewswire.com, essentialpharmagroup.com, uk.finance.yahoo.com and 2 more
$946M
Essential Pharma investors
3 investors have backed Essential Pharma; AlpInvest led at least one round.
- AlpInvest lead
- Sixth Street
What Essential Pharma does
Essential Pharma works in pharmaceutical products, with 16 recorded offerings and customers in healthcare and pharmaceuticals.
Essential Holdings Limited, known as Essential Pharma, is a British pharmaceutical company engaged in the development, manufacturing, and distribution of medicines for rare diseases, central nervous system, ophthalmology, gastroenterology, cardiovascular, dermatology, endocrinology, gynaecology, infectious diseases, and rheumatology. The company also acquires mature, branded medicines at risk of shortages or discontinuation, and manages a supply chain and logistics network to support global distribution. Essential Pharma operates internationally, with offices in multiple countries and a presence in over 70 markets.
Description from Veridion's company data.
Products and services
- Specialty Pharmaceutical Development
- Rare Disease Medicine Development
- CNS Medicine Development
- Ophthalmology Medicine Development
- Gastroenterology Medicine Development
- Cardiovascular Medicine Development
- Dermatology Medicine Development
- Endocrinology Medicine Development
- Gynaecology Medicine Development
- Infectious Disease Medicine Development
- Rheumatology Medicine Development
- Therapeutic Asset Acquisition and Commercialization
- Shortage Medicine Acquisition and Supply
- Clinical Development Asset Identification and Commercialization
- Patient-Centric Pharmaceutical Solutions
- Global Pharmaceutical Distribution
Markets
- Healthcare
- Pharmaceuticals
Supply chain
- Global Sourcing
- Strategic Sourcing
- Supplier Collaboration
- Sustainable Sourcing
Business model
- Business-to-Business
- Manufacturing
- Wholesale
Industry codes (NAICS)
- 325412 Pharmaceutical Preparation Manufacturing 70% match
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers 30% match
Questions about Essential Pharma
What is Essential Pharma worth?
Valuation $11.7B (range $5.3B to $17.8B), as of 24 Oct 2026.
Has Essential Pharma raised money?
Essential Pharma has 1 funding round on record, from Dec 2024 to Dec 2024, $946M in total. None disclosed a valuation.
Who has invested in Essential Pharma?
AlpInvest, Gyrus Capital and Sixth Street. Lead investors include AlpInvest.
How many people work at Essential Pharma?
About 122, up 17% over the last year. Headcount grew from 9 in Jan 2021 to 122 in Sep 2026.
What does Essential Pharma do?
Essential Pharma works in pharmaceutical products, with 16 recorded offerings and customers in healthcare and pharmaceuticals. Its main offerings are specialty pharmaceutical development, rare disease medicine development and CNS medicine development.
When was Essential Pharma founded, and where is it based?
Essential Pharma was founded in 2000 and is based in Egham, United Kingdom. It has about 122 employees, up 17% over the last year.